IIM
FHTX icon

INTECH Investment Management’s Foghorn Therapeutics FHTX Stock Holding History

INTECH Investment Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,576
Closed -$78.7K – 2198
2025
Q4 		$78.7K Sell
14,576
-1,621
-10% -$7.35K ﹤0.01% 2198
2025
Q3 		$79.2K Sell
16,197
-4,305
-21% -$22.8K ﹤0.01% 2312
2025
Q2 		$96.4K Buy
20,502
+27
+0.1% +$113 ﹤0.01% 2305
2025
Q1 		$74.7K Buy
+20,475
New +$93.3K ﹤0.01% 2376

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

INTECH Investment Management's FHTX Position: Q1 2026 in Review

INTECH Investment Management sold out of Foghorn Therapeutics (FHTX) in Q1 2026, closing a stake of 14,576 shares — an estimated $78.7K sold.

INTECH Investment Management first reported a position in FHTX in Q1 2025 and held it in 4 quarters. The position peaked at $96.4K in Q2 2025. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • INTECH Investment Management reported no remaining Foghorn Therapeutics position as of Q1 2026 after selling out during the quarter.
  • INTECH Investment Management sold 14,576 Foghorn Therapeutics shares in Q1 2026, an estimated $78.7K.
  • INTECH Investment Management first reported a position in Foghorn Therapeutics in Q1 2025 and held it in 4 quarters.
  • INTECH Investment Management's Foghorn Therapeutics position peaked at $96.4K in Q2 2025.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.